Eczema is one of the most frustrating skin conditions to live with at any age, from the helplessness of watching an infant scratch at inflamed skin to the chronic discomfort and unpredictable flares that follow children and adults through daily life, and Triple Paste Eczema Care is the first eczema portfolio from Triple Paste. With Baby & Children and Adult formulations, this launch carries the brand's two-step approach for finding relief, beginning with a Flare-Up Rescue Balm, then a Daily Barrier Cream.
Both calming skincare solutions feature Dual-Action Barrier Science, which harnesses clinically backed ingredients to address in-the-moment symptoms and long-term skin barrier health. Flare-Up Rescue Balm soothes irritation on contact with 2% FDA-approved colloidal oatmeal (twice the concentration found in most OTC eczema treatments) and the Baby & Children formulation is the category's first baby eczema product to incorporate ectoin.
What's Driving This Trend
- Two-step Eczema Care
- Layered treatment systems that pair fast flare relief with daily barrier maintenance create room for simplified routines that bridge acute symptom control and long-term skin health.
- Age-specific Dermocosmetics
- Separate formulations for babies, children and adults signal demand for condition-specific skincare that reflects different safety expectations, ingredient tolerances and usage habits.
- Barrier-science Skincare
- Clinically backed ingredients such as colloidal oatmeal and ectoin are reframing eczema products as science-led barrier repair solutions rather than basic moisturizers.
Who This Affects Most
- Skincare
- The category is being reshaped by therapeutic-positioned products that combine cosmetic usability with over-the-counter credibility for chronic skin concerns.
- Baby Care
- Infant-safe eczema innovations highlight white space for gentle, clinically validated products that address caregiver anxiety around sensitive skin flare-ups.
- Dermatology
- Consumer-facing eczema portfolios expand the role of dermatologist-inspired care by making advanced barrier support more accessible outside prescription channels.
